Fonte: Fortune
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.
Ler na Fonte
Notícias Relacionadas
Lista de Notícias
Fonte: Fortune
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.